Owkin is working with the Google on a plan to use its AI-based system on the health service's medical records. The NHS-backed firm, which uses predictive algorithms to identify biomarkers associated with cancer, would study hospital patient data in an effort to develop more effective drugs. Owkin, which is French-American and based in New York, is currently in negotiations with three large London academic medical centres over the scheme.
Owkin is working with the NHS on a plan to use its AI-based system on the health service's medical records. The Google-backed firm, which uses predictive algorithms to identify biomarkers associated with cancer, would study hospital patient data in an effort to develop more effective drugs. Owkin, which is French-American and based in New York, is currently in negotiations with three large London academic medical centres over the scheme.